NCT02153892View on ClinicalTrials.gov

Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

January 31, 2018

Conditions
Severe Functional Mitral Regurgitation and Heart Failure
Interventions
DEVICE

GDS Accucinch System

Percutaneous Coronary Intervention

Trial Locations (1)

3168

Monash Health, Melbourne

Sponsors

Lead Sponsor

Ancora Heart, Inc.
All Listed Sponsors
lead

Ancora Heart, Inc.

INDUSTRY

NCT02153892 - Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function | Biotech Hunter | Biotech Hunter